Acalabrutinib
Update Venetoclax in CLL
Obinutuzumab
(Update) Acalabrutinib in CLL and MCL
NCCN Guidelines for Patients
Leukemia & Lymphoma Society
ASCO: COVID-19 Medical Resources
UpToDate